Hormones and the cardiologist

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Women's Health

Background:

• Post-menopausal hormone therapy (HT) has been debated, particularly concerning cardiovascular outcomes.
• Emerging vascular biology research and epidemiological data suggest potential benefits of estrogen.
• Established coronary artery disease (CAD) and high cardiovascular risk necessitate careful consideration of treatment options.

Purpose of the Study:

• To emphasize the critical role of cardiologists in counseling post-menopausal women regarding hormone replacement therapy (HRT).
• To highlight the supporting evidence for estrogen's beneficial effects on coronary atherosclerosis.
• To advocate for informed discussion of HRT for selected high-risk women.

Main Methods:

• Review of epidemiological and observational data.
• Analysis of recent research in vascular biology.
• Clinical consideration of patient risk factors and established disease.

Main Results:

• Strong evidence supports estrogen's positive impact on the development and progression of coronary atherosclerosis.
• Potential benefits of HRT in managing cardiovascular risk in post-menopausal women.
• Cancer risks are acknowledged but should be weighed against cardiovascular benefits in select cases.

Conclusions:

• Cardiologists must actively engage in discussions about HRT for post-menopausal women with or at high risk for CAD.
• Informed counseling by cardiologists is essential for selected high-risk women to consider HRT.
• Balancing potential benefits against risks like cancer is crucial in personalized HRT recommendations.